These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 37006270)
1. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Lunardelli VAS; Almeida BDS; Apostolico JS; Rezende T; Yamamoto MM; Pereira SS; Bueno MFC; Pereira LR; Carvalho KI; Slhessarenko RD; de Souza Ferreira LC; Boscardin SB; Rosa DS Front Immunol; 2023; 14():1071041. PubMed ID: 37006270 [TBL] [Abstract][Full Text] [Related]
2. ZIKV-envelope proteins induce specific humoral and cellular immunity in distinct mice strains. Lunardelli VAS; de Souza Apostolico J; Souza HFS; Coirada FC; Martinho JA; Astray RM; Boscardin SB; Rosa DS Sci Rep; 2022 Sep; 12(1):15733. PubMed ID: 36131132 [TBL] [Abstract][Full Text] [Related]
3. Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses. Amaral MP; Apostolico JS; Tomita N; Coirada FC; Lunardelli VAS; Fernandes ER; Souza HFS; Astray RM; Boscardin SB; Rosa DS Vaccine; 2020 Apr; 38(20):3653-3664. PubMed ID: 32247567 [TBL] [Abstract][Full Text] [Related]
4. Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection. Qu P; Zhang W; Li D; Zhang C; Liu Q; Zhang X; Wang X; Dai W; Xu Y; Leng Q; Zhong J; Jin X; Huang Z Antiviral Res; 2018 Jun; 154():97-103. PubMed ID: 29665376 [TBL] [Abstract][Full Text] [Related]
5. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection. Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206 [TBL] [Abstract][Full Text] [Related]
6. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy. Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716 [TBL] [Abstract][Full Text] [Related]
7. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization. Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259 [TBL] [Abstract][Full Text] [Related]
8. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies. Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS mBio; 2019 Sep; 10(5):. PubMed ID: 31530669 [TBL] [Abstract][Full Text] [Related]
9. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model. Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774 [TBL] [Abstract][Full Text] [Related]
10. Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection. Zhang W; Qu P; Li D; Zhang C; Liu Q; Zou G; Dupont-Rouzeyrol M; Lavillette D; Jin X; Yin F; Huang Z Antiviral Res; 2019 Oct; 170():104578. PubMed ID: 31394119 [TBL] [Abstract][Full Text] [Related]
11. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge. De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720 [TBL] [Abstract][Full Text] [Related]
12. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Yang M; Dent M; Lai H; Sun H; Chen Q Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618 [TBL] [Abstract][Full Text] [Related]
13. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880 [TBL] [Abstract][Full Text] [Related]
14. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses. Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446 [TBL] [Abstract][Full Text] [Related]
16. Development of a neutralizing antibody targeting linear epitope of the envelope protein domain III of ZIKV. Hu H; Liu R; Li Q; Wang J; Deng Q; Lu Y; Wu Q; Chen Z; Lu J Virus Res; 2021 Dec; 306():198601. PubMed ID: 34678322 [TBL] [Abstract][Full Text] [Related]
17. Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus. Thomas A; Thiono DJ; Kudlacek ST; Forsberg J; Premkumar L; Tian S; Kuhlman B; de Silva AM; Metz SW J Virol; 2020 Aug; 94(18):. PubMed ID: 32611757 [TBL] [Abstract][Full Text] [Related]
18. Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice. Chen MY; Chai KM; Chiang CY; Wu CC; Yu GY; Liu SJ; Chen HW J Biomed Sci; 2020 Apr; 27(1):51. PubMed ID: 32290844 [TBL] [Abstract][Full Text] [Related]
19. Baculovirus Surface Display of Zika Virus Envelope Protein Protects against Virus Challenge in Mouse Model. Luo D; Miao Y; Ke X; Tan Z; Hu C; Li P; Wang T; Zhang Y; Sun J; Liu Y; Wang H; Zheng Z Virol Sin; 2020 Oct; 35(5):637-650. PubMed ID: 32472451 [TBL] [Abstract][Full Text] [Related]
20. Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice. To A; Medina LO; Mfuh KO; Lieberman MM; Wong TAS; Namekar M; Nakano E; Lai CY; Kumar M; Nerurkar VR; Lehrer AT mSphere; 2018; 3(1):. PubMed ID: 29359186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]